Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Historique:
received: 11 07 2019
revised: 26 12 2019
accepted: 06 02 2020
pubmed: 29 5 2020
medline: 30 9 2020
entrez: 29 5 2020
Statut: ppublish

Résumé

The population of patients with congenital heart disease (CHD) is continuously increasing, and a significant proportion of these patients will experience arrhythmias because of the underlying congenital heart defect itself or as a consequence of interventional or surgical treatment. Arrhythmias are a leading cause of mortality, morbidity and impaired quality of life in adults with CHD. Arrhythmias may also occur in children with or without CHD. In light of the unique issues, challenges and considerations involved in managing arrhythmias in this growing, ageing and heterogeneous patient population and in children, it appears both timely and essential to critically appraise and synthesize optimal treatment strategies. The introduction of catheter ablation techniques has greatly improved the treatment of cardiac arrhythmias. However, catheter ablation in adults or children with CHD and in children without CHD is more technically demanding, potentially causing various complications, and thus requires a high level of expertise to maximize success rates and minimize complication rates. As French recommendations regarding required technical competence and equipment are lacking in this situation, the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the Affiliate Group of Paediatric and Adult Congenital Cardiology have decided to produce a common position paper compiled from expert opinions from cardiac electrophysiology and paediatric cardiology. The paper details the features of an interventional cardiac electrophysiology centre that are required for ablation procedures in adults with CHD and in children, the importance of being able to diagnose, monitor and manage complications associated with ablations in these patients and the supplemental hospital-based resources required, such as anaesthesia, surgical back-up, intensive care, haemodynamic assistance and imaging. Lastly, the need for quality evaluations and French registries of ablations in these populations is discussed. The purpose of this consensus statement is therefore to define optimal conditions for the delivery of invasive care regarding ablation of arrhythmias in adults with CHD and in children, and to provide expert and - when possible - evidence-based recommendations on best practice for catheter-based ablation procedures in these specific populations.

Identifiants

pubmed: 32461091
pii: S1875-2136(20)30093-0
doi: 10.1016/j.acvd.2020.02.002
pii:
doi:

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

492-502

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Philippe Maury (P)

Department of Cardiology, Rangueil University Hospital, 31059 Toulouse, France. Electronic address: mauryjphil@hotmail.com.

Jean Benoit Thambo (JB)

Paediatric Cardiology Department, University Hospital Haut-Lévêque, 33604 Pessac, France.

Alice Maltret (A)

Paediatric Cardiology Department, Necker-Enfants Malades Hospital, AP-HP, M3C National Reference CHD Centre, Paris Descartes University, Sorbonne Paris Cité, 75015 Paris, France.

Nicolas Combes (N)

Clinique Pasteur, 31076 Toulouse, France.

Sébastien Hascoet (S)

Congenital Heart Disease Service, Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France.

Nicolas Derval (N)

Department of Cardiology, LIRYC Institute/Bordeaux University Hospital, 33600 Pessac, France.

Magalie Ladouceur (M)

Paris Descartes University, Sorbonne Paris Cité, 75006 Paris, France; Department of Cardiology, Georges Pompidou European Hospital and Necker-Enfants Malades Hospital, AP-HP, Adult Congenital Heart Disease Unit, Centre de Référence des Malformations Cardiaques Congénitales Complexes (M3C), 75015 Paris, France; Inserm U970, PARCC, 75015 Paris, France.

Philippe Acar (P)

Children's Hospital, Toulouse University Hospital, 31300 Toulouse, France.

Pascal Amedro (P)

Paediatric and Congenital Cardiology Department, M3C Regional Reference Centre, Montpellier University Hospital, PhyMedExp, CNRS, Inserm, University of Montpellier, 34295 Montpellier, France.

Frederic Anselm (F)

Department of Cardiology, Rouen University Hospital, 76000 Rouen, France.

Fanny Bajolle (F)

Paediatric Cardiology Department, Necker-Enfants Malades Hospital, AP-HP, M3C National Reference CHD Centre, Paris Descartes University, Sorbonne Paris Cité, 75015 Paris, France.

Adeline Basquin (A)

Department of Cardiology, Centre de Compétence M3C, Rennes University Hospital, 35000 Rennes, France.

Emre Belli (E)

Pôle des Cardiopathies Congénitales, Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France.

Pierre Bordachar (P)

Department of Cardiology, LIRYC Institute/Bordeaux University Hospital, 33600 Pessac, France.

Guillaume Duthoit (G)

Department of Cardiology, La Pitié-Salpétrière University Hospital, 75013 Paris, France.

Sylvie Di Filippo (S)

Department of Paediatric and Congenital Cardiology, Louis Pradel Hospital, 60500 Bron, France.

Laurent Fauchier (L)

Department of Cardiology, Tours University Hospital, 37000 Tours, France.

Estelle Gandjbakhch (E)

Department of Cardiology, La Pitié-Salpétrière University Hospital, 75013 Paris, France.

Daniel Gras (D)

Nouvelles Cliniques Nantaises, 44277 Nantes, France.

Celine Gronier (C)

Cabinet de Cardiologie Foetale Pediatrique et Congenitale Adulte et Groupement d'Exploration Radiologique et Cardiovasculaire, Clinique de l'Orangerie, 67000 Strasbourg, France.

Clement Karsenty (C)

Children's Hospital, Toulouse University Hospital, 31300 Toulouse, France.

Didier Klug (D)

Department of Cardiology, Lille University Hospital, 59000 Lille, France.

Linda Koutbi (L)

Paediatric and Congenital Medico-Surgical Cardiology Department, M3C Regional Reference CHD Centre, La Timone University Hospital, AP-HM, Laboratory of Medical Genetics, Inserm UMR 1251, Aix-Marseille University, 13385 Marseille, France.

Jérôme Lacotte (J)

Institut Cardiovasculaire Paris Sud, Jacques Cartier Private Hospital, 91300 Massy, France.

Gabriel Laurent (G)

Department of Cardiology, Dijon University Hospital, 21000 Dijon, France.

Daniela Laux (D)

Department of Paediatric and Congenital Cardiac Surgery, M3C, Marie Lannelongue Hospital, 92350 Le Plessis Robinson, France.

Jacques Mansourati (J)

Department of Cardiology, Brest University Hospital, 29200 Brest, France.

Eloi Marijon (E)

Department of Cardiology, Georges Pompidou European Hospital, 75015 Paris, France.

Caroline Ovaert (C)

Paediatric and Congenital Medico-Surgical Cardiology Department, M3C Regional Reference CHD Centre, La Timone University Hospital, AP-HM, Laboratory of Medical Genetics, Inserm UMR 1251, Aix-Marseille University, 13385 Marseille, France.

Frederic Sacher (F)

Department of Cardiology, LIRYC Institute/Bordeaux University Hospital, 33600 Pessac, France.

Nicolas Sadoul (N)

Department of Cardiology, Nancy University Hospital, 54035 Nancy, France.

Jérôme Taieb (J)

Department of Cardiology, Aix-en-Provence Hospital, 13616 Aix-en-Provence, France.

Victor Waldmann (V)

Department of Cardiology, Brest University Hospital, 29200 Brest, France.

Karine Warinfresse (K)

Department of Cardiovascular Imaging, Nantes University Hospital, 44800 Saint-Herblain, France.

Pascal Defaye (P)

Department of Cardiology, Grenoble University Hospital, 38700 La Tronche, France.

Olivier Piot (O)

Centre Cardiologique du Nord, 93200 Saint-Denis, France.

Serge Boveda (S)

Clinique Pasteur, 31076 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH